Yoshikane Kikushige

10PUBLICATIONS
26CO-AUTHORS
Molecular targetsGene and molecular therapyInstruments and techniquesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 05, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.

Gentaro Kawano, Riichiro Ikeda, Daisuke Ishihara

|May 22, 2025
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML.

Jian Zou, Haruka Kinosada, Shin-Ichiro Takayanagi

|Feb 20, 2025
Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RARĪ±.

Mariko Minami, Teppei Sakoda, Gentaro Kawano

|Dec 27, 2024
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.

Teppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune

|May 24, 2024
Immunology and targeted therapy in Castleman disease.

Shinichiro Tsunoda, Takuya Harada, Yoshikane Kikushige

|Mar 18, 2024
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.

Yasuo Mori, Jun Takizawa, Yuna Katsuoka

Pageof 2

Frequent Collaborators

3 joint publications

Koichi Akashi

2 joint publications

Yuya Kunisaki

2 joint publications

Kensuke Sasaki

1 joint publications

Koji Nagafuji